Fingerprint
Dive into the research topics of 'Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia
Farhad Ravandi, Susan O'Brien, Jeffrey Jorgensen, Sherry Pierce, Stefan Faderl, Alessandra Ferrajoli, Charles Koller, Pramoda Challagundla, Sergernne York, Mark Brandt, Rajyalakshmi Luthra, Jan Burger, Deborah Thomas, Michael Keating, Hagop Kantarjian
Research output: Contribution to journal › Article › peer-review
89
Scopus
citations